LDN193189 (GMP), CAS 1062368-24-4

Product Description: LDN193189 (DM-3189) (GMP) is LDN193189 (HY-12071) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. LDN193189 is selective BMP type I receptor inhibitor[1][2].

Applications: Cancer-Kinase/protease

Formula: C25H22N6

References: [1]Kim TW, et al. Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use. Cell Stem Cell. 2021 Feb 4;28(2):343-355.e5./[2]Pagliuca FW, et al. Generation of functional human pancreatic β cells in vitro. Cell. 2014 Oct 9;159(2):428-39.

CAS Number: 1062368-24-4

Molecular Weight: 406.48

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: TGF-β Receptor

• SKU: MEXHY-12071G-50
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-12071G-50
• Package Unit: 50 mg
• Quantity Unit: STK